William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
“Why did mammalian red cells give up their nucleus?
Most cells protect their nucleus.
Mammalian red cells do the opposite.
They eject it.
At first glance, this looks like a loss.
No DNA, no repair, no division. A finite lifespan.
But it is better understood as a trade-off.
Removing the nucleus allows the cell to remove something else too:
its mitochondria.
And with that, a potential conflict of interest.
A red cell that carries oxygen but also consumes it would compete with the tissues it serves.
By giving up mitochondria, the red cell commits fully to delivery.
It does not use the oxygen it transports.
It gives it away.
That same simplification has other consequences:
- more space for hemoglobin
- greater deformability in narrow capillaries
- fewer intracellular obstacles to diffusion
- educed capacity to support viral replication
But the central idea is this:
the red cell becomes a specialist by subtraction.
It gives up autonomy to eliminate internal competition and to optimize a single function.
Not every organism makes this choice.
Other vertebrates retain nucleated red cells.
Their constraints are different.
Mammals chose another path.
One that favors efficiency of delivery over cellular independence.
What looks like loss is the elimination of internal conflict.”
Read more on The Blood Project.

Find more posts featuring William Aird on Hemostasis Today.
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026
-
Jul 14, 2026, 11:21Malwina Maliszewska: Advancing Coagulation Diagnostics at ISTH 2026
-
Jul 14, 2026, 11:07Mary Cushman: Honoring Outstanding Mentorship at ISTH 2026
-
Jul 14, 2026, 10:53Maha Othman: Advancing the Management of Inherited Thrombocytopenias at ISTH 2026
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation